Patents by Inventor Filbert Totsingan

Filbert Totsingan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SOPHOROLIPID ESTER CHAIN LENGTH DEPENDENCE ON THE INHIBITION OF HUMAN PATHOGENS
    Publication number: 20170143753
    Abstract: A method for inhibitory and bactericidal activities against human pathogens by n-alkyl chain length of modified sophorolipid n-alkyl esters, and preferred n-alkyl chain lengths to enhance sophorolipid n-alkyl ester inhibitory and bactericidal activities against human pathogens.
    Type: Application
    Filed: November 19, 2016
    Publication date: May 25, 2017
    Applicant: Syntehzyme LLC
    Inventors: Richard A. Gross, Filbert Totsingan
  • DENDRIMERIC PEPTIDES, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME
    Publication number: 20150337011
    Abstract: Novel peptide compounds and pharmaceutical compositions thereof are disclosed that have a formula represented by the following formula (I) wherein L1, L2, L3, Z, R1, R2, R4 and R5 are as described herein. The compounds demonstrate antimicrobial activity and may be prepared as pharmaceutical compositions and used for the prevention and treatment of a variety of conditions in mammals including humans where microbial invasion is involved. The present peptides are particularly valuable as their effect is rapid, broad in spectrum and mostly indifferent to resistance provided by standard antibiotics.
    Type: Application
    Filed: July 31, 2015
    Publication date: November 26, 2015
    Inventors: Neville R. Kallenbach, Filbert Totsingan
  • Dendrimeric peptides, pharmaceutical compositions and methods of using the same
    Patent number: 9102712
    Abstract: Novel peptide compounds and pharmaceutical compositions thereof are disclosed that have a formula represented by the following formula (I) wherein L1, L2, L3, Z, R1, R2, R4 and R5 are as described herein. The compounds demonstrate antimicrobial activity and may be prepared as pharmaceutical compositions and used for the prevention and treatment of a variety of conditions in mammals including humans where microbial invasion is involved. The present peptides are particularly valuable as their effect is rapid, broad in spectrum and mostly indifferent to resistance provided by standard antibiotics.
    Type: Grant
    Filed: August 26, 2011
    Date of Patent: August 11, 2015
    Assignee: New York University
    Inventors: Filbert Totsingan, Neville Robert Kallenbach
  • DENDRIMERIC PEPTIDES, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME
    Publication number: 20130210706
    Abstract: Novel peptide compounds and pharmaceutical compositions thereof are disclosed that have a formula represented by the following formula (I) wherein L1, L2, L3, Z, R1, R2, R4 and R5 are as described herein. The compounds demonstrate antimicrobial activity and may be prepared as pharmaceutical compositions and used for the prevention and treatment of a variety of conditions in mammals including humans where microbial invasion is involved. The present peptides are particularly valuable as their effect is rapid, broad in spectrum and mostly indifferent to resistance provided by standard antibiotics.
    Type: Application
    Filed: August 26, 2011
    Publication date: August 15, 2013
    Inventors: Neville Robert Kallenbach, Filbert Totsingan